{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:58:14Z","timestamp":1793498294193,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To describe the characteristics, treatment, and outcomes of pregnant women with opioid use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Women attending an obstetric and addiction recovery clinic in Boston from 2015 to 2016 were enrolled in a prospective cohort study and followed through delivery (N=113). Buprenorphine or methadone was initiated clinically. The Addiction Severity Index was administered at enrollment. Prenatal and delivery data were systematically abstracted from medical charts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Most women in the cohort were non-Hispanic white (80.5%) with a mean age of 28 years. Few women were married (8.9%). More than half of the cohort had been incarcerated, 29.2% had current legal involvement, and 15.0% generally had unstable housing. A majority (70.8%) were infected with hepatitis C and histories of sexual (56.6%) and physical (65.5%) abuse were prevalent. Regular substance used included heroin (92.0%), injection heroin (83.2%), other opioids (69.0%), marijuana (73.5%), alcohol (56.6%), and cocaine (62.8%). Fifty-nine women (52.2%) were treated initially with prenatal buprenorphine and 54 (47.8%) with methadone; 49.6% also were taking concomitant psychotropic medications. Employment (0.766\u00b10.289) and psychologic (0.375\u00b10.187) Addiction Severity Index scores were the highest, indicating the most severe problems in these areas. Opioid use relapse did not differ by treatment (44.7% overall). Thirteen (22.5%) of 59 women treated with buprenorphine transitioned to methadone mainly because of positive opioid screens. Overall, 23.0% (n=26) of the cohort discontinued clinical care. The number of pregnancy losses was small (three therapeutic abortions, four miscarriages, one stillbirth), with an overall live birth rate of 90.8% (95% CI 82.7\u201395.9).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>These data on the social circumstances, substance use, treatment, and treatment outcomes of pregnant women with opioid use disorder may help clinicians to understand and treat this clinically complex population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000002881","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T16:27:44Z","timestamp":1537979264000},"page":"916-922","source":"Crossref","is-referenced-by-count":41,"title":["Prenatal Treatment and Outcomes of Women With Opioid Use Disorder"],"prefix":"10.1097","volume":"132","author":[{"given":"Susan B.","family":"Brogly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley E.","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.fertnstert.2017.06.007","article-title":"Women and the opioid crisis: historical context and public health solutions","volume":"108","author":"Terplan","year":"2017","journal-title":"Fertil Steril"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among Medicaid-enrolled women","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","first-page":"161","article-title":"Drug-induced deaths\u2014United States, 1999-2010","volume":"62","author":"Mack","year":"2013","journal-title":"MMWR Suppl"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10550887.2012.735566","article-title":"Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt","volume":"31","author":"Terplan","year":"2012","journal-title":"J Addict Dis"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwx341","article-title":"Neonatal outcomes in a Medicaid population with opioid dependence","volume":"187","author":"Brogly","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/AOG.0000000000002407","article-title":"Opioid knowledge and prescribing practices among obstetrician-gynecologists","volume":"131","author":"Madsen","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature","volume":"4","author":"Yazdy","year":"2015","journal-title":"J Pediatr Genet"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajo.2013.02.004","article-title":"The short- and long-term effects on the visual system of children following exposure to maternal substance misuse in pregnancy","volume":"156","author":"Spiteri Cornish","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9378(87)80029-7","article-title":"Cocaine use during pregnancy: adverse perinatal outcome","volume":"157","author":"MacGregor","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GRF.0b013e31827ae167","article-title":"The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy","volume":"56","author":"Cain","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"R14-20230711","first-page":"57","article-title":"Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications","volume":"6","author":"Minnes","year":"2011","journal-title":"Addict Sci Clin Pract"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","article-title":"The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome","volume":"5","author":"Wachman","year":"2011","journal-title":"J Addict Med"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.earlhumdev.2013.08.024","article-title":"Neonatal and longer term management following substance misuse in pregnancy","volume":"89","author":"Mactier","year":"2013","journal-title":"Early Hum Dev"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S0954579411000174","article-title":"The impact of sexual abuse on female development: lessons from a multigenerational, longitudinal research study","volume":"23","author":"Trickett","year":"2011","journal-title":"Dev Psychopathol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/AOG.0000000000000266","article-title":"Responding to prenatal disclosure of past sexual abuse","volume":"123","author":"White","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/AOG.0b013e31822c994d","article-title":"Adult manifestations of childhood sexual abuse. Committee Opinion No. 498. American College of Obstetricians and Gynecologists","volume":"118","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1518393112","article-title":"Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century","volume":"112","author":"Case","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0740-5472(96)00108-0","article-title":"A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours","volume":"14","author":"Copeland","year":"1997","journal-title":"J Subst Abuse Treat"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/GRF.0b013e31827feeb9","article-title":"Overview and epidemiology of substance abuse in pregnancy","volume":"56","author":"Wendell","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-016-0070-9","article-title":"Prenatal treatment for opioid dependency: observations from a large inner-city clinic","volume":"12","author":"Saia","year":"2017","journal-title":"Addict Sci Clin Pract"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/jwh.2011.3364","article-title":"Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study","volume":"21","author":"Perkins","year":"2012","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:17:20Z","timestamp":1689088640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002881","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}